Drugs / Hezkue
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07231185 | Jan → Mar 2026 overdue | erectile dysfunction | Aspargo Labs, Inc | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hezkue | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07231185 ↗ |
| Route | Oral | “Hezkue® is an oral liquid formulation of sildenafil administered on an on-demand basis for the treatment period.” NCT07231185 ↗ |